VG Life Sciences Secures Patent For Cell-Protective IBD Treatment
IBD News, News
VG Life Sciences (VGLS), a biotechnology company committed to developing therapies for infectious and autoimmune diseases, recently announced that the U.S. Patent and Trademark Office (USPTO) has issued the company a Patent No. 8906846 covering a ... Read more